Annexin A9 inhibitors are a class of compounds that are not defined by a specific chemical structure but by their ability to interfere with the function or interaction of Annexin A9 with other cellular components. The inhibitors listed are chemicals that can modulate cellular processes such as calcium signaling, membrane dynamics, and cell signaling pathways, all of which are important for the proper functioning of Annexin A9.
Annexin A9 inhibitors are calcium chelators that sequester free calcium ions, thus potentially disrupting the calcium-dependent binding of Annexin A9 to phospholipid membranes. The precise membrane association of Annexin A9 is critical for its function, and alterations in membrane phospholipids through inhibitors can lead to a functional inhibition of Annexin A9 by changing its lipid environment. Furthermore, inhibitors can indirectly affect Annexin A9 by altering the signaling pathways it is involved in. These inhibitors target various enzymes and receptors that are upstream of Annexin A9, thus altering its activation state or its ability to interact with other proteins. Lastly, inhibitors that affect the membrane composition and integrity can also be considered indirect inhibitors. In summary, the chemical class of Annexin A9 inhibitors encompasses a variety of compounds that, by different mechanisms, all converge on the modulation of Annexin A9's activity or its interactions with cellular components.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator that can disrupt calcium-dependent processes involving Annexin A9. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
A calcium chelator that, like BAPTA-AM, can interfere with calcium-dependent activities of Annexin A9. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can alter downstream signaling pathways, potentially influencing Annexin A9's role. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that may reduce calcium levels, thereby affecting Annexin A9's function. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-blocker that can influence signaling pathways, potentially altering Annexin A9 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that can modify cell signaling pathways, possibly affecting Annexin A9. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
An aminoglycoside antibiotic that can bind to phospholipids, potentially disrupting Annexin A9 interactions. | ||||||
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $53.00 $620.00 $1989.00 $133.00 | 8 | |
A compound that extracts cholesterol from membranes, possibly affecting the lipid environment of Annexin A9 | ||||||